BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20403734)

  • 21. The clinicopathologic differences of central lymph node metastasis in predicting lateral lymph node metastasis and prognosis in papillary thyroid cancer associated with or without Hashimoto's thyroiditis.
    Zhu Y; Zheng K; Zhang H; Chen L; Xue J; Ding M; Wu K; Wang Z; Kong L; Chen X
    Tumour Biol; 2016 Jun; 37(6):8037-45. PubMed ID: 26711787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of ultrasonographic features in predicting reginal lymph node metastasis in patients with papillary thyroid carcinoma].
    Shi WY; Hu MX; Zhu Q; Xia CX; Zhao Y; Zhou YJ; Fang YQ; Rong XX
    Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(27):2165-8. PubMed ID: 27464542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic significance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid carcinoma.
    Zhu X; Sun T; Lu H; Zhou X; Lu Y; Cai X; Zhu X
    J Clin Pathol; 2010 Sep; 63(9):786-9. PubMed ID: 20644217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma, a novel predictor for lymph node metastasis; possible morphological indicator of epithelial mesenchymal transition.
    Liu Z; Kakudo K; Bai Y; Li Y; Ozaki T; Miyauchi A; Taniguchi E; Mori I
    J Clin Pathol; 2011 Apr; 64(4):325-9. PubMed ID: 21296795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-overexpression of p53 protein and epidermal growth factor receptor in human papillary thyroid carcinomas correlated with lymph node metastasis, tumor size and clinicopathologic stage.
    Chen BK; Ohtsuki Y; Furihata M; Takeuchi T; Iwata J; Liang SB; Sonobe H
    Int J Oncol; 1999 Nov; 15(5):893-8. PubMed ID: 10536170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of c-Met protein in human thyroid tumors correlated with lymph node metastasis and clinicopathologic stage.
    Chen BK; Ohtsuki Y; Furihata M; Takeuchi T; Iwata J; Liang SB; Sonobe H
    Pathol Res Pract; 1999; 195(6):427-33. PubMed ID: 10399184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expressions of wildtype-RET and RET/PTC rearrangements in sporadic adult papillary thyroid carcinoma and their clinicopathologic correlation].
    Zhu XL; Zhou XY; Zhang TM; Zhu XZ
    Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):87-91. PubMed ID: 16630482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Papillary microcarcinomas of the thyroid with preoperatively detectable lymph node metastasis show significantly higher aggressive characteristics on immunohistochemical examination.
    Ito Y; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
    Oncology; 2005; 68(2-3):87-96. PubMed ID: 15886500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Values of ultrasound features and MMP-9 of papillary thyroid carcinoma in predicting cervical lymph node metastases.
    Zhang Y; Luo YK; Zhang MB; Li J; Li CT; Tang J; Li JL
    Sci Rep; 2017 Jul; 7(1):6670. PubMed ID: 28751724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement.
    Pizzolanti G; Russo L; Richiusa P; Bronte V; Nuara RB; Rodolico V; Amato MC; Smeraldi L; Sisto PS; Nucera M; Bommarito A; Citarrella R; Lo Coco R; Cabibi D; Lo Coco A; Frasca F; Gulotta G; Latteri MA; Modica G; Galluzzo A; Giordano C
    Thyroid; 2007 Nov; 17(11):1109-15. PubMed ID: 17727338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Papillary Thyroid Carcinoma Cervical Lymph Node Metastasis with Cystic Change Differentiated from Congenital Cystic Lesions with the Assistance of Immunohistochemistry: A Case Study.
    Liang Y; Zuo T
    Head Neck Pathol; 2017 Sep; 11(3):301-305. PubMed ID: 27770399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical value of Cyclin D1 and P21 in the differential diagnosis of papillary thyroid carcinoma.
    Wang CC; Lu DD; Shen MH; Chen RL; Zhang ZH; Lv JH
    Diagn Pathol; 2023 Nov; 18(1):123. PubMed ID: 37951919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between protein expression of VEGF-C, MMP-2 and lymph node metastasis in papillary thyroid cancer.
    Tian X; Cong M; Zhou W; Zhu J; Liu Q
    J Int Med Res; 2008; 36(4):699-703. PubMed ID: 18652765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer.
    Melck A; Masoudi H; Griffith OL; Rajput A; Wilkins G; Bugis S; Jones SJ; Wiseman SM
    Ann Surg Oncol; 2007 Dec; 14(12):3403-11. PubMed ID: 17882495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell cycle dysregulation influences survival in high risk breast cancer patients.
    Königsberg R; Rögelsperger O; Jäger W; Thalhammer T; Klimpfinger M; De Santis M; Hudec M; Dittrich C
    Cancer Invest; 2008 Aug; 26(7):734-40. PubMed ID: 18665474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomics study of serum exosomes from papillary thyroid cancer patients.
    Luo D; Zhan S; Xia W; Huang L; Ge W; Wang T
    Endocr Relat Cancer; 2018 Oct; 25(10):879-891. PubMed ID: 29895528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymph node metastasis in young and middle-aged papillary thyroid carcinoma patients: a SEER-based cohort study.
    Liu Y; Wang Y; Zhao K; Li D; Chen Z; Jiang R; Wang X; He X
    BMC Cancer; 2020 Mar; 20(1):181. PubMed ID: 32131769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of epidermal growth factor receptor and its downstream effector, focal adhesion kinase, correlates with papillary thyroid carcinoma progression.
    Šelemetjev S; Bartolome A; Išić Denčić T; Đorić I; Paunović I; Tatić S; Cvejić D
    Int J Exp Pathol; 2018 Apr; 99(2):87-94. PubMed ID: 29665129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristic tumor growth patterns as novel histomorphologic predictors for lymph node metastasis in papillary thyroid carcinoma.
    Jung YY; Lee CH; Park SY; Park HJ; Min HS; Won JK; Kim BS; Ryu HS
    Hum Pathol; 2013 Dec; 44(12):2620-7. PubMed ID: 24139209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of RET/PTC expression in papillary thyroid carcinoma and its correlation with prognostic factors in a north Indian population.
    Mishra A; Agrawal V; Krishnani N; Mishra SK
    J Postgrad Med; 2009; 55(3):171-5. PubMed ID: 19884740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.